-
1دورية أكاديمية
المصدر: Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-4 (2017)
مصطلحات موضوعية: Nivolumab, Ipilimumab, Dual checkpoint inhibitor therapy, Insulin-dependent diabetes mellitus and diabetic ketoacidosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://link.springer.com/article/10.1186/s40425-017-0303-9Test; https://doaj.org/toc/2051-1426Test
-
2
المصدر: Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-4 (2017)
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, endocrine system diseases, Diabetic ketoacidosis, medicine.medical_treatment, Immunology, Case Report, 030209 endocrinology & metabolism, Ipilimumab, lcsh:RC254-282, Diabetic Ketoacidosis, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Diabetes mellitus, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Immunology and Allergy, Neoplasm Metastasis, Melanoma, Insulin-dependent diabetes mellitus and diabetic ketoacidosis, Pharmacology, Type 1 diabetes, business.industry, Antibodies, Monoclonal, Type 2 Diabetes Mellitus, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Rash, Nivolumab, Endocrinology, Diabetes Mellitus, Type 2, 030220 oncology & carcinogenesis, Dual checkpoint inhibitor therapy, Molecular Medicine, medicine.symptom, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6870ab2ee63e859f2ff5b2c63ccd784dTest
https://doi.org/10.1186/s40425-017-0303-9Test